Effects of uncoupling protein 1 and β3-adrenergic receptor gene polymorphisms on body size and serum lipid concentrations in Japanese women

Maturitas

Volumn 45, Issue 1, 2003, Pages 39-45

  Matsushita, Hiroshi ^a   Kurabayashi, Takumi ^a   Tomita, Masatoshi ^a   Kato, Nozomi ^a   Tanaka, Kenichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Genetic polymorphisms; Lipid metabolism; Obesity; Uncoupling protein 1; 3 adrenergic receptor

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; CHOLESTEROL; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 1;

ADULT; ALLELE; ANTHROPOMETRY; ARTICLE; BODY MASS; BODY SIZE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; POSTMENOPAUSE; PREMENOPAUSE; STATISTICAL SIGNIFICANCE; WEIGHT GAIN;

EID: 0037499856     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(03)00088-4     Document Type: Article

References (26)

1. Kannel W.B. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am. Heart J. 114:1987;413-419.
2. Castelli W.P. Epidemiology of coronary heart disease: the Framingham Study. Am. J. Med. 76:1984;4-12.
3. Haarbo J., Hassager C., Riis B.J., Christiansen C. Relation of body fat distribution to serum lipids and lipoproteins in elderly women. Atherosclerosis. 80:1989;57-62.
4. Lean M.E.J. Brown adipose tissue in humans. Proc. Nutr. Soc. 48:1989;243-256.
5. Lowell B.B., Susulic V.S., Hamman A., et al. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature. 366:1993;740-742.
6. Hamman A., Benecke H., Marchand-Brustel Y.L., Susulic V.S., Lowell B.B., Flier J.S. Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes. 44:1995;1266-1273.
7. Oppert J.M., Vohl M.C., Chagnon M., et al. DNA polymorphism in the uncoupling protein (UCP) gene and human body fat. Int. J. Obes. 18:1994;526-531.
8. Cassard-Doulcier A.M., Bouillaud F., Chagnon M., et al. The Bcl I polymorphism of the human uncoupling protein (ucp) gene is due to a point mutation in the 5′-flanking region. Int. J. Obes. 20:1996;278-279.
9. Fumeron F., Durack-Bown I., Betoulle D., et al. Polymorphisms of uncoupling protein (UCP) and β3 adrenoreceptor genes in obese people submitted to a low calorie diet. Int. J. Obes. 20:1996;1051-1054.
10. Clément K., Ruiz J., Cassard-Doulcier A.M., et al. Additive effect of A→G (-3826) variant of the uncoupling protein gene and Trp64Arg mutation of the β3-adrenergic receptor gene on weight gain in morbid obesity. Int. J. Obes. 20:1996;1062-1066.
11. Heilbronn L.K., Kind K.L., Pancewicz E., Morris A.M., Noakes M., Clifton P.M. Association of -3826 G Variant in uncoupling protein-1 with increased BMI in overweight Australian women. Diabetologia. 43:2000;242-244.
12. 3-adrenoreceptor, uncoupling protein 1 and lipoprotein lipase with increased risk of metabolic complications in obesity. Int. J. Obes. 24:2000;93-100.
13. Hayakawa T., Nagai Y., Taniguchi M., et al. Phenotypic characterization of the β3-adrenergic receptor mutation and the uncoupling protein 1 polymorphism in Japanese men. Metabolism. 48:1999;636-640.
14. 3-adrenergic-receptor gene. New Engl. J. Med. 333:1995;343-347.
15. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. New Engl. J. Med. 333:1995;348-351.
16. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid. New Engl. J. Med. 333:1995;352-354.
17. Kurabayashi T., Carey D.G.P., Morrison N.A. The β3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women: effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes. 45:1996;1358-1363.
18. Kim-Motoyama H., Yasuda K., Yamaguchi T., et al. A mutation of the β3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia. 40:1997;469-472.
19. Friedewald W.T., Levy R.I., Fredrick D.S. Estimation of the concentration of low density lipoprotein in plasma without use of a preparative ultracentrifuge. Clin. Chem. 18:1972;449-456.
20. 3-adrenergic receptor genes on basal metabolic rate in obese Finns. Diabetologia. 41:1998;357-361.
21. Schäffler A., Palitzsch K.D., Watzlawek E., et al. Frequency and significance of the A→G (-3826) polymorphism in the promoter of the gene for uncoupling protein-I with regard to metabolic parameters and adipocyte transcription factor binding in a large population-based Caucasian cohort. Eur. J. Clin. Invest. 29:1999;770-779.
22. Gagnon J., Lago F., Chagnon Y.C., et al. DNA polymorphism in the uncoupling protein 1 (UCP1) gene has no effect on obesity related phenotypes in the Swedish Obese Subjects cohorts. Int. J. Obes. 22:1998;500-505.
23. 3-adrenergic receptor genes on weight loss in obese Japanese. Diabetologia. 41:1998;1399. letter.
24. Esterbauer H., Oberkofler H., Liu Y.M., et al. Uncoupling protein-1 mRNA expression in obese human subjects: the role of sequence variations at the uncoupling protein-1 gene locus. J. Lipid Res. 39:1998;834-844.
25. Nagase I., Yoshida T., Kumamoto K., et al. Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic β3-adrenergic agonist. J. Clin. Invest. 97:1996;2898-2904.
26. Pedersen S.B., Bruun J.M., Kristensen K., Richelsen B. Regulation of UCP1, UCP2, and UCP3 mRNA expression in brown adipose tissue, white adipose tissue, and skeletal muscle in rats by estrogen. Biochem. Biophys. Res. Commun. 288:2001;191-197.